324 related articles for article (PubMed ID: 29544460)
1. The curious case of Gαs gain-of-function in neoplasia.
Innamorati G; Wilkie TM; Kantheti HS; Valenti MT; Dalle Carbonare L; Giacomello L; Parenti M; Melisi D; Bassi C
BMC Cancer; 2018 Mar; 18(1):293. PubMed ID: 29544460
[TBL] [Abstract][Full Text] [Related]
2. McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation with GNAS somatic mutation - a case report.
Gaujoux S; Pasmant E; Silve C; Mehsen-Cetre N; Coriat R; Rouquette A; Douset B; Prat F; Leroy K
Medicine (Baltimore); 2019 Dec; 98(50):e18102. PubMed ID: 31852070
[TBL] [Abstract][Full Text] [Related]
3. Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: : GNAS-activating mutations in pancreatic carcinogenesis.
Parvanescu A; Cros J; Ronot M; Hentic O; Grybek V; Couvelard A; Levy P; Chanson P; Ruszniewski P; Sauvanet A; Gaujoux S
JAMA Surg; 2014 Aug; 149(8):858-62. PubMed ID: 24898823
[TBL] [Abstract][Full Text] [Related]
4. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
Lietman SA; Ding C; Levine MA
J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125
[TBL] [Abstract][Full Text] [Related]
5. Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas.
Wood LD; Noë M; Hackeng W; Brosens LA; Bhaijee F; Debeljak M; Yu J; Suenaga M; Singhi AD; Zaheer A; Boyce A; Robinson C; Eshleman JR; Goggins MG; Hruban RH; Collins MT; Lennon AM; Montgomery EA
Virchows Arch; 2017 Apr; 470(4):391-400. PubMed ID: 28188442
[TBL] [Abstract][Full Text] [Related]
6. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
[TBL] [Abstract][Full Text] [Related]
7. A New Multisystem Disorder Caused by the Gαs Mutation p.F376V.
Biebermann H; Kleinau G; Schnabel D; Bockenhauer D; Wilson LC; Tully I; Kiff S; Scheerer P; Reyes M; Paisdzior S; Gregory JW; Allgrove J; Krude H; Mannstadt M; Gardella TJ; Dattani M; Jüppner H; Grüters A
J Clin Endocrinol Metab; 2019 Apr; 104(4):1079-1089. PubMed ID: 30312418
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Radiographic Gastrointestinal Abnormalities in McCune-Albright Syndrome.
Robinson C; Estrada A; Zaheer A; Singh VK; Wolfgang CL; Goggins MG; Hruban RH; Wood LD; Noë M; Montgomery EA; Guthrie LC; Lennon AM; Boyce AM; Collins MT
J Clin Endocrinol Metab; 2018 Nov; 103(11):4293-4303. PubMed ID: 30124968
[TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary and Pancreatic neoplasms in patients with McCune-Albright syndrome.
Gaujoux S; Salenave S; Ronot M; Rangheard AS; Cros J; Belghiti J; Sauvanet A; Ruszniewski P; Chanson P
J Clin Endocrinol Metab; 2014 Jan; 99(1):E97-101. PubMed ID: 24170100
[TBL] [Abstract][Full Text] [Related]
10. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome.
Vortmeyer AO; Gläsker S; Mehta GU; Abu-Asab MS; Smith JH; Zhuang Z; Collins MT; Oldfield EH
J Clin Endocrinol Metab; 2012 Jul; 97(7):2404-13. PubMed ID: 22564667
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Spectrum of McCune-Albright Syndrome and Its Management.
Spencer T; Pan KS; Collins MT; Boyce AM
Horm Res Paediatr; 2019; 92(6):347-356. PubMed ID: 31865341
[TBL] [Abstract][Full Text] [Related]
12. [The activating GNAS mutation : A survey of fibrous dysplasia, its associated syndromes, and other skeletal and extraskeletal lesions].
Ostertag H; Glombitza S
Pathologe; 2018 Mar; 39(2):146-153. PubMed ID: 29488004
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Molin MD; Matthaei H; Wu J; Blackford A; Debeljak M; Rezaee N; Wolfgang CL; Butturini G; Salvia R; Bassi C; Goggins MG; Kinzler KW; Vogelstein B; Eshleman JR; Hruban RH; Maitra A
Ann Surg Oncol; 2013 Nov; 20(12):3802-8. PubMed ID: 23846778
[TBL] [Abstract][Full Text] [Related]
14. GNAS Mutations: Drivers or Co-Pilots? Yet, Promising Diagnostic Biomarkers.
Innamorati G; Valenti MT; Giacomello L; Dalle Carbonare L; Bassi C
Trends Cancer; 2016 Jun; 2(6):282-285. PubMed ID: 28741526
[TBL] [Abstract][Full Text] [Related]
15. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
[TBL] [Abstract][Full Text] [Related]
16. Activating GNAS mutations in parosteal osteosarcoma.
Carter JM; Inwards CY; Jin L; Evers B; Wenger DE; Oliveira AM; Fritchie KJ
Am J Surg Pathol; 2014 Mar; 38(3):402-9. PubMed ID: 24525511
[TBL] [Abstract][Full Text] [Related]
17. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.
Weinstein LS; Shenker A; Gejman PV; Merino MJ; Friedman E; Spiegel AM
N Engl J Med; 1991 Dec; 325(24):1688-95. PubMed ID: 1944469
[TBL] [Abstract][Full Text] [Related]
18. Familial Pancreatic Intraductal Papillary and Mucinous Neoplasms Do Not Carry Constitutional or Postzygotic GNAS Activating Mutations.
Gaujoux S; Parvanescu A; Fusco G; Linglart A; Sauvanet A; Couvelard A; Levy P; Rebours V; Cros J
Pancreas; 2021 Feb; 50(2):e14-e15. PubMed ID: 33565803
[No Abstract] [Full Text] [Related]
19. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.
Takano S; Fukasawa M; Maekawa S; Kadokura M; Miura M; Shindo H; Takahashi E; Sato T; Enomoto N
PLoS One; 2014; 9(6):e98718. PubMed ID: 24897499
[TBL] [Abstract][Full Text] [Related]
20. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.
Weinstein LS; Yu S; Warner DR; Liu J
Endocr Rev; 2001 Oct; 22(5):675-705. PubMed ID: 11588148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
